MESA TECH INTERNATIONAL, INC.

Medtech · Private

Instrumentation-free, disposable nucleic acid point-of-care diagnostic device for rapid multiplex detection of respiratory pathogens

Grants
$2.0M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$8.9M
3 awards · Commerce, Defense, Health and Human S
#75 of 4531 in medtech
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Commerce · Purchase Mircoarrays$15,000
Federal contractDepartment of Defense · Igf::ot::igf Base Period$8,322,936
Federal grantDepartment of Health and Human Services · Phase II · Rapid, disposable, nucleic acid diagnostic device for multiplexed point of care f$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Rapid, disposable, nucleic acid diagnostic device for multiplexed point of care f$1,000,000
Federal contractDepartment of Health and Human Services · COVID-19 - Mesa Biotech, Inc. - Research&development Of Qualitative, Visually-read Pcr Test.$561,330
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
72SHARP VISION SOFTWARE LLC$9.6M—
73Rapid Micro Biosystems$9.3M$120M
74PLATYPUS TECHNOLOGIES LLC$9.2M$154K
75MESA TECH INTERNATIONAL, INC.$8.9M—
76QOOLABS INC$8.8M—
77SCIGLOB INSTRUMENTS & SERVICES LLC$8.8M—
78MYOMO INC$8.6M$6.8M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Oscillating Amplification Reaction For Nucleic Acidsapplication
  • Integrated Device For Nucleic Acid Detection And Identificationapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.